Study design approaches for future active-controlled HIV prevention trials is a research paper published in Statistical Communications in Infectious Diseases (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: U01AI068617
National Institute of Allergy and Infectious Diseases
Grant: UM1AI068635
The Second European & Developing Countries Clinical Trials Partnership
Grant: RIA-2016V-1644
National Institutes of Health
Grant: 3UM1AI068635-17S4
CoVPN 3001 - A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults.
National Institutes of Health
Grant: 5U01AI068617-05
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network
Medical Research Council
Grant: MC_PC_20056
Medical Research Council
Grant: MC_UU_00004/03
Medical Research Council
Grant: MC_UU_00033/1
NIAID NIH HHS
Grant: R01 AI143357
NIAID NIH HHS
Grant: UM1 AI068617
FWCI
1.76
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals